OnKure Therapeutics, Inc. (OKUR) Misses Q4 EPS by 130c

OnKure Therapeutics, Inc. (NASDAQ: OKUR) reported Q4 EPS of ($1.37), $1.30 worse than the analyst estimate of ($0.07).

For earnings history and earnings-related data on OnKure Therapeutics, Inc. (OKUR) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Ionic Digital backs Texas data center audit amid grid reliability push
• XP Inc. (XP) Tops Q2 EPS by 8c